Immunization of sheep with a combination of intiminγ, EspA and EspB decreases Escherichia coli O157:H7 shedding

Veterinary Immunology and Immunopathology

Volumn 140, Issue 1-2, 2011, Pages 42-46

  Yekta, M Atef ^a   Goddeeris, B M ^a,b   Vanrompay, D ^a   Cox, E ^a  

^a GHENT UNIVERSITY   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

E. coli O157:H7; Sheep; Vaccination

Indexed keywords

BACTERIAL PROTEIN; ESCHERICHIA COLI SECRETED PROTEIN A; ESCHERICHIA COLI SECRETED PROTEIN B; IMMUNOGLOBULIN G ANTIBODY; MEMBRANE PROTEIN; OUTER MEMBRANE PROTEIN INTIMIN GAMMA; TRANSLOCON; UNCLASSIFIED DRUG; ADHESIN; BACTERIUM ANTIBODY; EAEA PROTEIN, E COLI; EAEB PROTEIN, E COLI; ESCHERICHIA COLI PROTEIN; ESCHERICHIA COLI VACCINE; ESPA PROTEIN, E COLI; OUTER MEMBRANE PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL SHEDDING; BACTERIAL STRAIN; BACTERIUM CULTURE; CONTROLLED STUDY; ENTEROHEMORRHAGIC ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; FECES CULTURE; IMMUNIZATION; IMMUNOGLOBULIN BLOOD LEVEL; MALE; MOUTH INFECTION; NONHUMAN; PLASMID; RUMINANT STOMACH; SHEEP; ANIMAL; ANIMAL DISEASE; BLOOD; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI O157; FECES; IMMUNOLOGY; ISOLATION AND PURIFICATION; MICROBIOLOGY; VACCINATION; ZOONOSIS;

BOS; ESCHERICHIA COLI; OVIS ARIES;

ADHESINS, BACTERIAL; ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI O157; ESCHERICHIA COLI PROTEINS; ESCHERICHIA COLI VACCINES; FECES; MALE; SHEEP; VACCINATION; ZOONOSES;

EID: 79961002080     PISSN: 01652427     EISSN: 18732534     Source Type: Journal    
DOI: 10.1016/j.vetimm.2010.11.010     Document Type: Article

References (32)

1. Besser R.E., Griffin P.M., Slutsker L. Escherichia coli O157:H7 gastroenteritis and the hemolytic uremic syndrome: an emerging infectious disease. Annu. Rev. Med. 1999, 50:355-367.
2. Borczyk A.A., Karmali M.A., Lior H., Duncan L.M.C. Bovine reservoir for verotoxin-producing Escherichia coli O157:H7. Lancet 1987, 1:98-198.
3. Brashears M.M., Galyean M.L., Loneragan G.H., Mann J.E., Killinger-Mann K. Prevalence of Escherichia coli O157:H7 and performance by beef feedlot cattle given Lactobacillus direct-fed microbials. J. Food Prot. 2003, 66:748-754.
4. Callaway T.R., Anderson R.C., Edrington T.S., Genovese K.J., Bischoff K.M., Poole T.L., Jung Y.S., Harvey R.B., Nisbet D.J. What are we doing about Escherichia coli O157:H7 in cattle?. J. Anim. Sci. 2004, 82:93-99.
5. Cray W.C., Moon H.W. Experimental infection of calves and adult cattle with Escherichia coli O157:H7. Appl. Environ. Microbiol. 1995, 61:1586-1590.
6. Cox E., Verdonck F., Vanrompay D., Goddeeris B. Adjuvants modulating mucosal immune responses or directing systemic responses towards the mucosa. Vet. Res. 2006, 37:511-539.
7. Dean-Nystrom E.A., Bosworth B.T., Moon H.W. Pathogenesis of Escherichia coli O157:H7 in weaned calves. Adv. Exp. Med. Biol. 1999, 473:173-177.
8. Dean-Nystrom E.A., Bosworth B.T., Cray W.C., Moon H.W. Pathogenicity of Escherichia coli O157:H7 in the intestines of neonatal calves. Infect. Immun. 1997, 65:1842-1848.
9. Dibb-Fuller M.P., Best A., Stagg D.A., Cooley W.A., Woodward M.J. An in vitro model for studying the interaction of Escherichia coli O157:H7 and other enteropathogens with bovine primary cell cultures. J. Med. Microbiol. 2001, 50:759-769.
10. Dziva F., Vlisidou I., Crepin V.F., Wallis T.S., Frankel G., Stevens M.P. Vaccination of calves with EspA, a key colonisation factor of Escherichia coli O157:H7, induces antigen specific humoral responses but does not confer protection against intestinal colonisation. Vet. Microbiol. 2007, 123:254-261.
11. Ebel F., Podzadel T., Rohde M., Kresse A.U., Kramer S., Deibel C., Guzman C.A., Chakraborty T. Initial binding of Shiga toxin producing Escherichia coli to host cells and subsequent induction of actin rearrangements depend on filamentous EspA containing surface appendages. Mol. Microbiol. 1998, 30:147-161.
12. Frankel G., Phillips A.D., Rosenshine I., Dougan G., Kaper J.B., Knutton S. Enteropathogenic and enterohaemorrhagic Escherichia coli: more subversive elements. Mol. Microbiol. 1998, 30:911-921.
13. Hartland E.L., Daniell S.J., Delahay R.M., Neves B.C., Wallis T., Shaw R.K., Hale C., Knutton S., Frankel G. The type III protein translocation system of enteropathogenic Escherichia coli involves EspA, EspB protein interactions. Mol. Microbiol. 2000, 35:1483-1492.
14. Karpman D., Bekassy Z.D., Sjogren A.C., Dubois M.S., Karmali M.A., Mascarenhas M., Jarvis K.G., Gansheroff L.J., O'Brien A.D., Arbus G.S., Kaper J.B. Antibodies to intimin and Escherichia coli secreted proteins A and B in patients with enterohemorrhagic Escherichia coli infections. Pediatr. Nephrol. 2002, 17:201-211.
15. Knutton S., Rosenshine I., Pallen M.J., Nisan I., Neves B.C., Bain C., Wolff C., Dougan G., Frankel G. A novel EspA-associated surface organelle of enteropathogenic Escherichia coli involved in protein translocation into epithelial cells. EMBO J. 1998, 17:2166-2176.
16. Matthews L., McKendrick I.J., Ternent H., Gunn G.J., Synge B., Woolhouse M.E. Super-shedding cattle and the transmission dynamics of Escherichia coli O157. Epidemiol. Infect. 2006, 134:131-142.
17. McNeilly T.N., Mitchell M.C., Rosser T., McAteer S., Low J.C., Smith D.G., Huntley J.F., Mahajan A., Gally D.L. Immunization of cattle with a combination of purified intimin-531, EspA and Tir significantly reduces shedding of Escherichia coli O157:H7 following oral challenge. Vaccine 2010, 28:1422-1428.
18. Moxley R.A. Escherichia coli O157:H7: an update on intestinal colonization and virulence mechanisms. Anim. Health Res. Rev. 2004, 5:15-33.
19. Moxley R.A., Smith D.R., Luebbe M., Erickson G.E., Klopfenstein T.J., Rogan D. Escherichia coli O157:H7 vaccine dose-effect in feedlot cattle. Foodborne Pathog. Dis. 2009, 6:879-884.
20. Naylor S.W., Gally D.L., Low J.C. Enterohaemorrhagic E. coli in veterinary medicine. Int. J. Med. Microbiol. 2005, 295:419-441.
21. Naylor S.W., Low J.C., Besser T.E., Mahajan A., Gunn G.J., Pearce M.C., McKendrick I.J., Smith D.G.E., Gally D.L. Lymphoid follicle-dense mucosa at the terminal rectum is the principal site of colonization of enterohemorrhagic Escherichia coli O157:H7 in the bovine host. Infect. Immun. 2003, 71:1505-1512.
22. Potter A.A., Klashinsky S., Li Y.L., Frey E., Townsend H., Rogan D., Erickson G., Hinkley S., Klopfenstein T., Moxley R.A., Smith D.R., Finlay B.B. Decreased shedding of Escherichia coli O157:H7 by cattle following vaccination with type III secreted proteins. Vaccine 2004, 22:362-369.
23. Sinclair J.F., O'Brien A.D. Intimin types alpha, beta, and gamma bind to nucleolin with equivalent affinity but lower avidity than to the translocated intimin receptor. J. Biol. Chem. 2004, 32:33751-33758.
24. Smith D.R., Moxley R.A., Peterson R.E., Klopfenstein T.J., Erickson G.E., Clowser S.L. A two-dose regimen of a vaccine against Escherichia coli O157:H7 type III secreted proteins reduced environmental transmission of the agent in a large-scale commercial beef feedlot clinical trial. Foodborne Pathog. Dis. 2008, 5:589-598.
25. Smith D.R., Moxley R.A., Peterson R.E., Klopfenstein T.J., Erickson G.E., Bretschneider G., Berberov E.M., Clowser S. A Two dose regimen of a vaccine against Type III Secreted Proteins reduced Escherichia coli O157:H7 colonization of the terminal rectum in beef cattle in commercial feedlots. Foodborne Pathog. Dis. 2009, 6:155-161.
26. Tutenel A.V., Pierard D., Vandekerchove D., Van Hoof J., De Zutter L. Sensitivity of methods for the isolation of Escherichia coli O157 from naturally infected bovine faeces. Vet. Microbiol. 2003, 94:341-346.
27. van Diemen P.M., Dziva F., Abu-Median A., Wallis T.S., van den Bosch H., Dougan G., Chanter N., Frankel G., Stevens M.P. Subunit vaccines based on intimin and Efa-1 polypeptides induce humoral immunity in cattle but do not protect against intestinal colonisation by enterohaemorrhagic Escherichia coli O157:H7 or O26:H-. Vet. Immunol. Immunopathol. 2007, 15:47-58.
28. Van Donkersgoed J., Hancock D., Rogan D., Potter A.A. Escherichia coli O157:H7 vaccine field trial in 9 feedlots in Alberta and Saskatchewan. Can. Vet. J. 2005, 46:724-728.
29. VandeWalle K., Atef Yekta M., Verdonck F., Dezutter L., Cox E. Rectal inoculation of sheep with E. coli O157:H7 results in persistent infection in the absence of a protective immune response. Vet. Microbiol. 2010, doi:10.1016/j.vetmic.2010.06.033.
30. Wales A.D., Clifton-Hadley F.A., Cookson A.L., Dibb-Fuller M.P., Laragione R.M., Pearson G.R., Woodward M.J. Production of attaching-effacing lesions in ligated large intestine loops of 6-month-old sheep by Escherichia coli O157: H7. J. Med. Microbiol. 2002, 51:755-763.
31. Wolff C., Nisan I., Hanski E., Frankel G., Rosenshine I. Protein translocation into host epithelial cells by infecting enteropathogenic Escherichia coli. Mol. Microbiol. 1998, 28:143-155.
32. Woodward M.J., Best A., Sprigings K.A., Pearson G.R., Skuse A.M., Wales A., Hayes C.M., Roe J.M., Low J.C., La Ragione R.M. Non-toxigenic Escherichia coli O157:H7 strain NCTC12900 causes attaching-effacing lesions and eae-dependent persistence in weaned sheep. Int. J. Med. Microbiol. 2003, 293:299-308.